The response in US would be much better, as investors over there understand the value of Orphan drug status for rare diseases. Just keep on holding fellows, Hopefully they will be spike tomorrow. Australians investors biased towards mining.
One more news about presentation about the revenue and countries they can use this drug for the treatment would be awesome. , I have reached my limit of buying. It will be silly to sell now as we are not far from FDA approval
Ann: FDA Grants Orphan Drug Designation for Revascor, page-52
-
- There are more pages in this discussion • 221 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.5¢ |
Change
0.010(1.09%) |
Mkt cap ! $1.056B | |||
| Open | High | Low | Value | Volume |
| 90.5¢ | 94.0¢ | 89.5¢ | $4.970M | 5.436M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 18877 | 92.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.5¢ | 6795 | 1 |
View Market Depth
| Last trade - 16.10pm 08/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |